Cellegy, Biosyn deal

CLGY said it will acquire Biosyn for 2.5 million shares, valuing Biosyn at $10.6 million

Read the full 157 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE